Bejerot

Lindesmith and Bejerot - Could They Meet Today?

The antagonists in the drug policy field, Alfred Lindesmith and Nils Bejerot, made completely different conclusions in the past. Could they have agreed today? IBH President Robert L. DuPont, MD presents an analysis in DrugNews. After reviewing this history, he notes, “Bejerot saw clearly the risks of compromising with drug use and the value of labeling this use as unhealthy and unacceptable. Sweden provides a model for the world in drug policy today.” Read more.

Back to Top ↑